Description

Iowa Association of Pathologists Biennial Meeting

Date: Friday, May 17, 2024

Time: 5:15 pm

Location: Graduate Hotel, Iowa City

REGISTRATION CLOSES MAY 10, 2024.

Agenda

5:15 – 6:15 pm

Reception and Networking

6:15 – 6:30 pm

Welcome from IAP President

Dr. Beth Kilborn, Iowa Pathology Associates

6:30 – 7:00 pm

Dinner 

7:00 – 7:30 pm

Updates on Private Health Plans and Prior Authorization

Dr. Theresa S. Emory, Vice-Chair, Economic Affairs Committee, College of American Pathologists

7:30 - 8:30 pm

Maximizing the Diagnosis of Common Cutaneous Neoplasms and Dermatopathology Mimics (CME approved)

Dr. Brian Swick, UIHC

8:30 pm

Thank You and Conclusion

Dr. Beth Kilborn, Iowa Pathology Associates

Hotel Information

A block of rooms has been reserved at the Graduate Hotel. Please use this link to book a room by April 14, 2024: 

Iowa Association of Pathologists Graduate IC

CME Information

Des Moines University is the accredited provider and has approved this educational offering. If you have questions regarding continuing education credit, please email cme@dmu.edu.

ACCREDITATION STATEMENTS

• MD: This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Iowa Medical Society (IMS) through the joint providership of Des Moines University (DMU) and the Iowa Medical Society. DMU is accredited by IMS to provide continuing medical education for physicians. DMU designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
• DO: Des Moines University (DMU) is accredited by the American Osteopathic Association (AOA) to provide osteopathic continuing medical education for physicians. DMU designates this program for a maximum of 1.0 AOA Category 2-A credits and will report CME and specialty credits commensurate with the extent of the physician’s participation in this activity.
• Other Health Professionals: This live activity is designated for a maximum of 1.0 AMA PRA Category 1 Credit(s)™.

EDUCATIONAL GRANTS

No ineligible company provided financial support for this continuing education activity.

DISCLOSURE

The speaker(s) will disclose if any pharmaceuticals, medical procedures, and devices discussed are investigational or unapproved by the U.S. Food and Drug Administration (FDA). The determination of educational content and the selection of speakers is the responsibility of the activity director.

Relevant to the content of this educational activity, the following individuals have no conflict(s) with ineligible companies to disclose.

• Beth Kilborn, MD - Activity Director and Planning Committee Member
• Mary Lyon - Activity Coordinator and Planning Committee Member
• Brian L. Swick, MD, FAAD - Speaker

DISCLAIMER

The information provided in this activity is for continuing education. It is not meant to substitute for the independent medical judgment of a healthcare provider relative to diagnostic and treatment options of a specific patient’s medical condition. The content of each presentation does not necessarily reflect the views of Des Moines University.